webmaster-prism

Whether you’re an emerging manufacturer putting the finishing touches on a new product launch or a small to mid-sized company whose products are outgrowing the post-launch support infrastructure you have in place, Two Labs provides expert consultative services to ensure your product can keep pace with constantly changing market dynamics. Additional indications, formulation changes, altered patient populations, and labeling changes are a few of the catalysts that can obsolete [...]

  In its simplest form, an order set is like a decision tree for healthcare providers. At the top of the tree are the diagnostics and tests, and based on the results and disease state, physicians can follow specific branches of treatment that best match the patient’s needs, including scans, care procedures, and drugs.  Order sets are created based on consensus from each healthcare system’s physicians. Any tests, procedures, and [...]

  Have you finalized your plans for Asembia yet? As you’re mapping out your schedule, don’t forget to join us for our cell and gene panel presentation on May 4 from 9:30-10:15 AM called “How the Cell & Gene Journey Shifted Over Time — And Where It’s Going Next.” The panel features Kyle Felmet, Vice President, Specialty Commercialization at Two Labs and Cynthia Hwang, Senior Vice President, Government Pricing Programs [...]

The Asembia countdown is on and we can hardly wait! There’s nothing quite like Asembia, especially if you’re currently in the weeds of launching your specialty pharmacy product. Whether you’re in need of a new 3PL partner, are hoping to learn about all the possible tech solutions that can support your launch, or are looking for information on what’s driving the specialty pharmacy industry forward, Asembia is for you. What [...]

Patient Services have become a must-have for any specialty product launching today. Many pharmaceutical clients are looking to expand their reach and offer enhanced services to their patients, particularly in a competitive landscape. So what makes a good program GREAT?  It all starts with identifying needs: Who are my patients? Who are the healthcare providers? Which services may have the greatest impact? [...]

As the world's largest single pharmaceutical market, the US should – at least at first glance – provide a simplified pathway for companies looking for a stateside translation of their successes in Europe’s patchwork quilt of countries. Unfortunately, that's anything but the case. In this white paper, Howard Miller, CEO of Two Labs, discusses how companies looking to replicate a drug’s EU market success in the US will [...]

There’s an undeniable truth in the pharmaceutical industry: the success of your product relies on the ability of patients, healthcare providers, and caregivers to understand how to access and use it. From reimbursement and financial hurdles to access and adherence challenges, to distribution obstacles, there are a plethora of barriers that manufacturers must devise a strategy to alleviate. And that’s exactly what makes a robust Patient Services strategy [...]